DULAGLUTIDE (TRULICITY) prior authorization at Horizon Blue Cross Blue Shield of New Jersey
Submission criteria, P2P prep, and appeal path if denied — for prescribers and PA staff
The PA criteria you'll need to meet
Horizon Blue Cross Blue Shield of New Jersey reviews DULAGLUTIDE (TRULICITY) prior authorizations against its medical policy for GLP-1 Receptor Agonist [EPC]. The FDA-approved indication (2014) is INJECTABLE. Horizon Blue Cross Blue Shield of New Jersey-specific context: Only BCBS licensee in New Jersey; ~3.7M members. OMNIA Health Plans (tiered network) generate frequent appeals — tier-2 hospital usage carries higher cost share. NJ DOBI oversight; NJ has a strong external review program (IHCAP via Maximus).
Documentation packet checklist
- Chart note with diagnosis (ICD-10 code) and clinical severity markers
- Documented failure of, contraindication to, or intolerance of step-therapy alternatives in GLP-1 Receptor Agonist [EPC]
- Prior treatment history including dosing, duration, and reason for discontinuation
- Relevant labs, imaging, or assessment scores supporting medical necessity
- Prescriber attestation linking the FDA-approved indication to the patient's presentation
- Horizon Blue Cross Blue Shield of New Jersey's medical policy URL referenced in the cover letter
Horizon Blue Cross Blue Shield of New Jersey's common denial patterns
Pre-empting these patterns in the initial submission cuts rework and shortens time-to-approval:
- OMNIA tier-1 vs tier-2 provider disputes
- Step therapy on biologics
- Behavioral health prior auth
- Out-of-state emergency reductions
If the PA is denied
Horizon Blue Cross Blue Shield of New Jersey gives prescribers and members 180 days to file an internal appeal. Standard appeal decisions return within 30 days. Submit through the provider portal (https://www.horizonblue.com/providers) with the same packet plus a peer-reviewed citation supporting DULAGLUTIDE (TRULICITY)for the patient's indication.
Contact Horizon Blue Cross Blue Shield of New Jersey
- Provider portal: https://www.horizonblue.com/providers
Frequently asked questions
What documentation does Horizon Blue Cross Blue Shield of New Jersey need for DULAGLUTIDE (TRULICITY) prior auth?
Horizon Blue Cross Blue Shield of New Jersey's typical PA packet for DULAGLUTIDE (TRULICITY): (1) chart note documenting the indication and prior-treatment failures, (2) supporting lab/imaging where indicated, (3) prescriber attestation that step-therapy alternatives were tried or contraindicated, (4) FDA-approved indication mapped to ICD-10 diagnosis. For GLP-1 Receptor Agonist [EPC], expect clinical-criteria documentation specific to this class.
What's the turnaround time at Horizon Blue Cross Blue Shield of New Jersey?
Standard DULAGLUTIDE (TRULICITY) PA decisions at Horizon Blue Cross Blue Shield of New Jersey: 30 days. Urgent / expedited (member's life or function at risk): 72 hours under 45 CFR §147.136.
What does Horizon Blue Cross Blue Shield of New Jersey most often reject DULAGLUTIDE (TRULICITY) for?
Across Horizon Blue Cross Blue Shield of New Jersey's book the common rejection patterns include: OMNIA tier-1 vs tier-2 provider disputes; Step therapy on biologics; Behavioral health prior auth. For DULAGLUTIDE (TRULICITY) specifically, expect step-therapy challenges and indication-restriction reviews when the use is at the edge of the FDA label or off-label.
How do I prep for a peer-to-peer with Horizon Blue Cross Blue Shield of New Jersey on DULAGLUTIDE (TRULICITY)?
Lead with the FDA-approved indication and the specific clinical criteria the policy lists. Have the patient's chart open, document number, and policy URL on screen. State your name and credentials, the policy number, the indication, and the documented failures of step-therapy alternatives. Keep notes — if the P2P reviewer overturns, get the decision in writing.
Generate the DULAGLUTIDE (TRULICITY) PA packet
Open ApprovalHelp — generate a DULAGLUTIDE (TRULICITY) prior-auth packet tailored to Horizon Blue Cross Blue Shield of New Jersey's criteria, with prescriber attestation and step-therapy documentation pre-filled.
Get started →Contact: hello@approvalhelp.com